These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 16627811)

  • 21. Sex steroid hormones induce acylation stimulating protein resistance in 3T3-L1 adipocytes.
    Wen Y; Wang H; MacLaren R; Lu H; Hu XF; Cianflone K
    J Cell Biochem; 2008 Oct; 105(2):404-13. PubMed ID: 18615583
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contribution of mutations in low density lipoprotein receptor (LDLR) and lipoprotein lipase (LPL) genes to familial combined hyperlipidemia (FCHL): a reappraisal by using a resequencing approach.
    Minicocci I; Prisco C; Montali A; Di Costanzo A; Ceci F; Pigna G; Arca M
    Atherosclerosis; 2015 Oct; 242(2):618-24. PubMed ID: 26342331
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Pro12A1a substitution in the peroxisome proliferator activated receptor gamma 2 is associated with an insulin-sensitive phenotype in families with familial combined hyperlipidemia and in nondiabetic elderly subjects with dyslipidemia.
    Pihlajamäki J; Miettinen R; Valve R; Karjalainen L; Mykkänen L; Kuusisto J; Deeb S; Auwerx J; Laakso M
    Atherosclerosis; 2000 Aug; 151(2):567-74. PubMed ID: 10924736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of gemfibrozil versus simvastatin in familial combined hyperlipidemia and effects on apolipoprotein-B-containing lipoproteins, low-density lipoprotein subfraction profile, and low-density lipoprotein oxidizability.
    Bredie SJ; de Bruin TW; Demacker PN; Kastelein JJ; Stalenhoef AF
    Am J Cardiol; 1995 Feb; 75(5):348-53. PubMed ID: 7856526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular genetic evidence for a founder effect in familial hypercholesterolemia among French Canadians.
    Bétard C; Kessling AM; Roy M; Chamberland A; Lussier-Cacan S; Davignon J
    Hum Genet; 1992 Mar; 88(5):529-36. PubMed ID: 1348044
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two novel apolipoprotein A-IV variants in individuals with familial combined hyperlipidemia and diminished levels of lipoprotein lipase activity.
    Deeb SS; Nevin DN; Iwasaki L; Brunzell JD
    Hum Mutat; 1996; 8(4):319-25. PubMed ID: 8956036
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The V73M mutation in the hepatic lipase gene is associated with elevated cholesterol levels in four Dutch pedigrees with familial combined hyperlipidemia.
    Hoffer MJ; Snieder H; Bredie SJ; Demacker PN; Kastelein JJ; Frants RR; Stalenhoef AF
    Atherosclerosis; 2000 Aug; 151(2):443-50. PubMed ID: 10924721
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complex genetic contribution of the Apo AI-CIII-AIV gene cluster to familial combined hyperlipidemia. Identification of different susceptibility haplotypes.
    Dallinga-Thie GM; van Linde-Sibenius Trip M; Rotter JI; Cantor RM; Bu X; Lusis AJ; de Bruin TW
    J Clin Invest; 1997 Mar; 99(5):953-61. PubMed ID: 9062353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The lipoprotein lipase (Asn291-->Ser) mutation is associated with elevated lipid levels in families with familial combined hyperlipidaemia.
    Hoffer MJ; Bredie SJ; Boomsma DI; Reymer PW; Kastelein JJ; de Knijff P; Demacker PN; Stalenhoef AF; Havekes LM; Frants RR
    Atherosclerosis; 1996 Jan; 119(2):159-67. PubMed ID: 8808493
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The hormone sensitive lipase gene in familial combined hyperlipidemia and insulin resistance.
    Pihlajamäki J; Valve R; Karjalainen L; Karhapää P; Vauhkonen I; Laakso M
    Eur J Clin Invest; 2001 Apr; 31(4):302-8. PubMed ID: 11298776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum C3 but not plasma acylation-stimulating protein is elevated in Finnish patients with familial combined hyperlipidemia.
    Ylitalo K; Pajukanta P; Meri S; Cantor RM; Mero-Matikainen N; Vakkilainen J; Nuotio I; Taskinen MR
    Arterioscler Thromb Vasc Biol; 2001 May; 21(5):838-43. PubMed ID: 11348883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bimodality of plasma apolipoprotein B levels in familial combined hyperlipidemia.
    Austin MA; Horowitz H; Wijsman E; Krauss RM; Brunzell J
    Atherosclerosis; 1992 Jan; 92(1):67-77. PubMed ID: 1575822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The effect of micronized fenofibrate on lipid parameters and fibrinogen in heterozygous familial hypercholesterolemia and familial combined hyperlipidemia].
    Ceska R; Sobra J; Kvasnicka J; Procházková R; Kvasilová M; Haas T
    Cas Lek Cesk; 1996 Jul; 135(13):413-6. PubMed ID: 8925538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel variant in LPL gene is associated with familial combined hyperlipidemia.
    Taghizadeh E; Ghayour-Mobarhan M; Ferns GA; Pasdar A
    Biofactors; 2020 Jan; 46(1):94-99. PubMed ID: 31599081
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular screening of the lipoprotein lipase gene in hypertriglyceridemic members of familial noninsulin-dependent diabetes mellitus families.
    Elbein SC; Yeager C; Kwong LK; Lingam A; Inoue I; Lalouel JM; Wilson DE
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1450-6. PubMed ID: 7962342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolism of apolipoprotein B in members of a family with accelerated atherosclerosis: influence of apolipoprotein E-3/E-2 pattern.
    Haffner SM; Kushwaha RS; Hazzard WR
    Metabolism; 1992 Mar; 41(3):241-5. PubMed ID: 1542261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein-B kinetics in man: normolipemic subjects, familial hypertriglyceridemia and familial combined hyperlipidemia.
    Kissebah AH; Alfarsi S; Adams PW
    Metabolism; 1981 Sep; 30(9):856-68. PubMed ID: 7266376
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Single nucleotide polymorphisms of the very low density lipoprotein receptor (VLDLR) gene.
    Near SE; Wang J; Hegele RA
    J Hum Genet; 2001; 46(8):490-3. PubMed ID: 11501949
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of two novel LDL receptor gene defects in French-Canadian pediatric population: mutational analysis and biochemical studies.
    Assouline L; Leitersdorf E; Lambert M; Reshef A; Feoli-Fonseca JC; Levy E
    Hum Mutat; 1997; 9(6):555-62. PubMed ID: 9195230
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipoprotein and apolipoprotein abnormalities in familial combined hyperlipidemia: a 20-year prospective study.
    McNeely MJ; Edwards KL; Marcovina SM; Brunzell JD; Motulsky AG; Austin MA
    Atherosclerosis; 2001 Dec; 159(2):471-81. PubMed ID: 11730829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.